Geron Corporation (GERN) Social Stream
Geron Corp (GERN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Geron Corp.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
GERN's average price target has moved up $0.5 over the prior 14 months.
Over the past 48 weeks, GERN's average upside potential has been 208.27%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
GERN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
GERN's average broker recommendation rating improved by 0 over the prior 24 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GERN as an investment opportunity.
- In the context of all US stocks, Geron Corp's average analyst price target is higher than 4.5% of them.
- In the context of all US stocks, Geron Corp's variance in analysts' estimates is lower than -78.56% of them.
- GERN has a higher number of analysts covering the stock than 35.58% of Pharmaceutical Products stocks.
- Geron Corp's upside potential (average analyst target price relative to current price) is higher than 136.82% of stocks in the small market cap category.
Is GERN a Buy, Hold or Sell? See the POWR Ratings now!